about
Identification of druggable cancer driver genes amplified across TCGA datasetsEpigenetic pathways and glioblastoma treatmentJARID1B is a luminal lineage-driving oncogene in breast cancerReversible disruption of mSWI/SNF (BAF) complexes by the SS18-SSX oncogenic fusion in synovial sarcomaVprBP has intrinsic kinase activity targeting histone H2A and represses gene transcriptionEpigenetic effects of green tea polyphenols in cancerEpigenetic Activation of Wnt/β-Catenin Signaling in NAFLD-Associated HepatocarcinogenesisStress-triggered atavistic reprogramming (STAR) addiction: driving force behind head and neck cancer?Where Environment Meets Cognition: A Focus on Two Developmental Intellectual Disability DisordersMultiple Functions of Ten-eleven Translocation 1 during TumorigenesisEpigenetics and inheritance of phenotype variation in livestockBig Data Analytics for Prostate RadiotherapyRegulation of the Telomerase Reverse Transcriptase Subunit through Epigenetic MechanismsSpermatogonial stem cell autotransplantation and germline genomic editing: a future cure for spermatogenic failure and prevention of transmission of genomic diseasesEpigenetic therapy in gastrointestinal cancer: the right combinationEpigenetics: A possible answer to the undeciphered etiopathogenesis and behavior of oral lesionsDNA Methylation and Chromatin Remodeling: The Blueprint of Cancer EpigeneticsInhibition of histone deacetylases in cancer therapy: lessons from leukaemiaThe Role of Gammaherpesviruses in Cancer PathogenesisEchoes of the embryo: using the developmental biology toolkit to study cancerIntegration of genome scale data for identifying new players in colorectal cancerMammalian SWI/SNF chromatin remodeling complexes and cancer: Mechanistic insights gained from human genomicsInterplay between Transcription Factors and the Epigenome: Insight from the Role of RUNX1 in LeukemiaProgress in epigenetic histone modification analysis by mass spectrometry for clinical investigationsOsteosarcoma Genetics and Epigenetics: Emerging Biology and Candidate TherapiesTowards an understanding of the role of DNA methylation in rheumatoid arthritis: therapeutic and diagnostic implicationsThe role and mechanism of CRL4 E3 ubiquitin ligase in cancer and its potential therapy implicationsThe complexity of epigenetic diseasesDysregulated metabolism contributes to oncogenesisFuture Clinical Trials in DIPG: Bringing Epigenetics to the ClinicEpigenetic mechanisms underlying the link between non-alcoholic fatty liver diseases and nutritionCombining genomic and proteomic approaches for epigenetics researchEpigenetic alterations of the Wnt signaling pathway in cancer: a mini reviewEpigenetic regulation by histone demethylases in hypoxiaATP-dependent chromatin remodeling complexes as novel targets for cancer therapyTargeting histone deacetylases for cancer therapy: from molecular mechanisms to clinical implicationsEpigenetics: the fine-tuner in inflammatory bowel disease?Keep-ING balance: tumor suppression by epigenetic regulationMolecular characteristics of pediatric high-grade gliomasMechanisms of epigenetic regulation of leukemia onset and progression
P2860
Q21090621-5964DC41-2364-4DE4-8E8C-A17C6ACC4842Q24273294-7BA49171-FCFC-422D-A805-83F54382D065Q24299326-199F4119-0BF0-4429-925B-DDE47DB017EDQ24337483-0A4EFDB1-2B6C-4236-8B83-3429DBFF1F57Q24338707-A0E11209-BC69-4440-A51E-761158C9A2C4Q24568216-E9E0C24A-473B-4D88-8CCE-455967C2BE18Q26739018-A0C437C0-4BE4-48DF-B6AD-86A890ADE7F7Q26739748-C6BCF5D0-ED39-40D1-88C9-866B234302D5Q26740071-B53C7691-E8A2-48F3-B71F-1EB5A9C8F32CQ26740522-573EB0CA-4FC6-45C6-886B-3EC78C4BA4FCQ26742131-DD00C497-3A38-442A-B35B-88EF2EC9E30BQ26744485-A508649B-ADDB-4092-BBB9-ED37852803FAQ26744572-F9F3A833-D1C3-4D55-B956-4A2A2F9F60DBQ26744780-2B43917E-9990-46C7-852D-D9B2837DCA7EQ26745709-F9CF14A3-DF25-494F-BF78-FB12A44F8884Q26748531-D3304E51-47CF-4ED1-83B1-E691443DBADAQ26749421-E74DE34B-B51B-4C5D-845B-216A16CBA8E8Q26767024-A7558901-18D0-4706-A822-979E48132974Q26767186-EE86CEB1-4C58-48E2-8B55-02D8604BCE01Q26770157-0A35191C-9AB4-427F-8440-889496D7EC9CQ26774701-C4283596-EB6D-46E3-93D0-F56734E52356Q26776098-80C2C108-397F-41BE-9358-AF800A6F24C5Q26781526-80A27647-A98C-46A3-A95A-F40BB5B6EC7BQ26781745-6F13A173-DA16-4294-86C5-FA9B11C012FBQ26782646-F0D8DF98-DFD9-44D7-8A13-48DA40EC4FE9Q26783490-A64180E8-97F8-4E01-AAF8-CECC5FEA0B3BQ26783814-7C3ABCD5-972A-445E-A220-9D545E0FFE2BQ26784416-F6A39DDD-487D-4AA6-8DEF-BCEE6E31CF9EQ26784630-E64EF168-4377-4C9E-B7ED-0788ACA6B2AFQ26801858-34A6D161-B523-418E-87D3-D4F8F17117B5Q26822513-7C55C5F5-BA68-4A12-9176-4A43DE9F8389Q26824645-BCFDB223-3209-4967-91DF-0F000BEB661FQ26824835-85C334D5-E6A7-4DAF-A107-4D78FF6046BBQ26825704-F668200D-45F7-4814-A0FB-7A0A3A13E32CQ26849467-207F596C-DCAC-403F-A559-F59975BB6D94Q26853394-754F2338-6262-46F3-90C8-2504A6050D41Q26853555-CF213946-103B-4E01-8AAA-68F53F127C36Q26859017-C5FE9660-3AE7-4BA3-B5A1-90D78986CBAFQ26860786-734E2905-8235-4920-8991-EE7EAE0EC7F1Q26861785-4B6E08C5-049C-4397-8621-0D39BE4EC93D
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Cancer epigenetics: from mechanism to therapy
@ast
Cancer epigenetics: from mechanism to therapy
@en
type
label
Cancer epigenetics: from mechanism to therapy
@ast
Cancer epigenetics: from mechanism to therapy
@en
prefLabel
Cancer epigenetics: from mechanism to therapy
@ast
Cancer epigenetics: from mechanism to therapy
@en
P3181
P1433
P1476
Cancer epigenetics: from mechanism to therapy
@en
P2093
Kouzarides T
P3181
P356
10.1016/J.CELL.2012.06.013
P407
P577
2012-07-01T00:00:00Z